GCP Inspections: Corrective Measures For Adverse Findings Should Be Tested, US FDA Says

 
• By Sue Sutter
  
Derailed train
FDA wants to see processes in place to ensure that clinical trial operations don't go "off the rails" again. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D